Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds

被引:51
作者
Yang, WD [1 ]
Gomes, RR [1 ]
Alicknavitch, M [1 ]
Farach-Carson, MC [1 ]
Carson, DD [1 ]
机构
[1] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA
来源
TISSUE ENGINEERING | 2005年 / 11卷 / 1-2期
关键词
D O I
10.1089/ten.2005.11.76
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Perlecan, a heparan sulfate proteoglycan, is widely distributed in developing and adult tissues and plays multiple, important physiological roles. Studies with knockout mouse models indicate that expression of perlecan and heparan sulfate is critical for proper skeletal morphogenesis. Heparan sulfate chains bind and potentiate the activities of various growth factors such as fibroblast growth factor 2 (FGF-2). Previous studies indicate that important biological activities are associated with the heparan sulfate-bearing domain I of perlecan ( PlnDI; French et al. J. Bone Miner. Res. 17, 48, 2002). In the present study, we have used recombinant, glycosaminoglycan-bearing PlnDI to reconstitute three-dimensional scaffolds of collagen I. Collagen I fibrils bound PlnDI much better than native collagen I monomers or heat-denatured collagen I preparations. Heparitinase digestion demonstrated that recombinant PlnDI was substituted with heparan sulfate and that these heparan sulfate chains were critically important not only for efficient integration of PlnDI into scaffolds, but also for FGF-2 binding and retention. PlnDI-containing collagen I scaffolds to which FGF-2 was bound sustained growth of both MG63, an osteoblastic cell line, and human bone marrow stromal cells (hBMSCs) significantly better than scaffolds lacking either PlnDI or FGF-2. Collectively, these studies demonstrate the utility of PlnDI in creating scaffolds that better mimic natural extracellular matrices and better support key biological activities.
引用
收藏
页码:76 / 89
页数:14
相关论文
共 59 条
[1]   Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition [J].
Allen, BL ;
Filla, MS ;
Rapraeger, AC .
JOURNAL OF CELL BIOLOGY, 2001, 155 (05) :845-857
[2]   Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library [J].
Ashikari-Hada, S ;
Habuchi, H ;
Kariya, Y ;
Itoh, N ;
Reddi, AH ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12346-12354
[3]   Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA [J].
Aviezer, D ;
Iozzo, RV ;
Noonan, DM ;
Yayon, A .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :1938-1946
[4]   PERLECAN, BASAL LAMINA PROTEOGLYCAN, PROMOTES BASIC FIBROBLAST GROWTH FACTOR-RECEPTOR BINDING, MITOGENESIS, AND ANGIOGENESIS [J].
AVIEZER, D ;
HECHT, D ;
SAFRAN, M ;
EISINGER, M ;
DAVID, G ;
YAYON, A .
CELL, 1994, 79 (06) :1005-1013
[5]   Host response to tissue engineered devices [J].
Babensee, JE ;
Anderson, JM ;
McIntire, LV ;
Mikos, AG .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) :111-139
[6]   The extracellular matrix as a scaffold for tissue reconstruction [J].
Badylak, SE .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2002, 13 (05) :377-383
[7]   PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines [J].
Bilbe, G ;
Roberts, E ;
Birch, M ;
Evans, DB .
BONE, 1996, 19 (05) :437-445
[8]  
Blanquaert F, 1999, J BIOMED MATER RES, V44, P63, DOI 10.1002/(SICI)1097-4636(199901)44:1<63::AID-JBM7>3.0.CO
[9]  
2-S
[10]   Molecular signaling in bioengineered tissue microenvironments [J].
Bottaro, DP ;
Liebmann-Vinson, A ;
Heidaran, MA .
REPARATIVE MEDICINE: GROWING TISSUES AND ORGANS, 2002, 961 :143-153